Related Experiment Video
Updated: Jul 18, 2026

Methods for ECG Evaluation of Indicators of Cardiac Risk, and Susceptibility to Aconitine-induced Arrhythmias in Rats Following Status Epilepticus
Published on: April 5, 2011
Relationship between serum potassium concentration and risk of recurrent ventricular tachycardia or ventricular
G F Michaud1, C Sticherling, H Tada
1Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor 48109-0022, USA.
Insights
Electrolyte abnormalities, like low potassium, do not significantly increase the risk of recurrent ventricular arrhythmias in patients with structural heart disease. Implantable defibrillators may still be reasonable for these patients.
Area of Science:
- Cardiology
- Electrophysiology
- Internal Medicine
Background:
- Electrolyte abnormalities are cited as a correctable cause of life-threatening ventricular arrhythmias.
- Current guidelines recommend defibrillator implantation for ventricular tachycardia or fibrillation with electrolyte abnormalities, but supporting data are limited.
Purpose of the Study:
- To investigate the risk of recurrent sustained ventricular arrhythmia in patients with low serum potassium at the time of an initial event.
Main Methods:
- A cohort of 169 patients with sustained ventricular arrhythmia and available serum potassium levels underwent defibrillator implantation.
- Patients had structural heart disease and a mean ejection fraction of 0.32 ± 0.15.
- Serum potassium levels were categorized as <3.5 mEq/L, 3.5–5.0 mEq/L, or >5.0 mEq/L.
Main Results:
- 30% of patients had abnormal serum potassium (<3.5 or >5.0 mEq/L) at the time of the initial arrhythmia.
- Five-year freedom from recurrent sustained ventricular arrhythmia was 18% for the entire cohort.
- No significant difference in recurrence-free survival was observed across different potassium level groups (P = 0.1).
Conclusions:
- Abnormal serum potassium at the time of initial ventricular arrhythmia in patients with structural heart disease may indicate high risk for recurrence.
- Implantable defibrillator therapy may be a reasonable consideration for these patients.
Introduction:
Electrolyte abnormalities are considered a correctable cause of a life-threatening ventricular arrhythmia according to American Heart Association/American College of Cardiology Practice Guidelines, and ventricular tachycardia or ventricular fibrillation in the setting of an electrolyte abnormality is considered a class III indication for defibrillator implantation. However, there are little data to support this recommendation. The purpose of this study was to determine the risk of a recurrent sustained ventricular arrhythmia in patients with a low serum potassium concentration at the time of an initial episode of a sustained ventricular arrhythmia.
Methods And Results:
One hundred sixty-nine consecutive patients who presented with a sustained ventricular arrhythmia and a serum potassium concentration determined on the day of the arrhythmia underwent defibrillator implantation. All patients had structural heart disease and left ventricular ejection fraction of 0.32+/-0.15. On the day of the index arrhythmia, 30% of the patients had a serum potassium concentration <3.5 or >5.0 mEq/L, including 7% who had a serum potassium concentration <3.0 or >6.0 mEq/L. For the entire cohort of patients, freedom from a recurrent sustained ventricular arrhythmia was 18% at 5 years and was not significantly different among patients with a serum potassium concentration <3.5 mEq/L (23%), between 3.5 and 5.0 mEq/L (16%), and >5.0 mEq/L (5%; P = 0.1).
Conclusion:
The results of the present study suggest that patients with structural heart disease and an abnormal serum potassium concentration at the time of an initial episode of sustained ventricular tachycardia or ventricular fibrillation are at high risk for a recurrent ventricular arrhythmia; therefore, implantable defibrillator therapy may be reasonable.
Related Concept Videos
Antihypertensive Drugs: Potassium-Sparing Diuretics
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Dysrhythmias II: Classification of Tachyarrhythmias
Dysrhythmias III: Characteristics of Dysrhythmias
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

